Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 1997

View Archived Issues

Human SMC migration factor and modulators thereof described by SKB and HGS

GnRH conjugate vaccines prepared at Merck & Co.

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

Chiroscience reports PDE/TNF inhibitors

Trovafloxacin extensively covered at recent congress

Efficacy reported for FR-167653 in animal model of septic shock

Nasal vs. rectal midazolam as premedication in children

New emulsion formulation of tacrolimus provides local immunosuppression

JTV-506 shows potential for asthma

Prosorba column trial for rheumatoid arthritis to continue

New protease inhibitor from HMR characterized

Cypros licenses patents for CPC-111 in organ transplant

SAR described for small-molecule ETA antagonists from ImmunoPharmaceutics

FDA approves Niaspan for the treatment of mixed lipid disorders

Research Triangle Institute investigates compounds for male fertility control

Potent and selective AMPA antagonist discovered by Yamanouchi

Device for snoring cleared by FDA

FDA to regulate ultrasound contrast agents as drugs

FDA advisory panel recommends nonapproval of Heart Laser TMR System

Molecular Biosystems' Optison reclassified as drug

New Japanese distribution agreement for Cortecs' H. pylori test

Licenses offered for cell replication technology

Daiichi's new anticancer agent enters overseas clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...